PFKM Antibody

Phosphofructokinase Muscle, Mouse Anti Human
Cat. No.
BT22203
Source
Synonyms
EC 2.7.1.11, GSD7, PFK-1, PFK1, PFKA, PFKX, Phosphofructokinase-M, Phosphofructokinase 1, Phosphohexokinase, Phosphofructo-1-kinase isozyme A, MGC8699, PFKM. 
Appearance
Sterile Filtered colorless solution.
Purity
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Product Specs

Introduction
PFKM, a key regulatory enzyme in glycolysis, catalyzes the conversion of fructose 6-phosphate to fructose 1,6-bisphosphate (via PFK-1) and fructose 2,6-bisphosphate (via PFK-2) using ATP. Humans possess three PFKM isozymes: muscle, liver, and platelet. Genetic mutations in the PFKM gene are linked to glycogen storage disease type VII, also known as Tarui disease.
Physical Appearance
A clear, sterile-filtered solution.
Formulation
The solution is at a concentration of 1mg/ml and contains PBS at pH 7.4, 10% glycerol, and 0.01% sodium azide.
Storage Procedures
For storage up to 1 month, maintain the product at 4°C. For longer-term storage, store at -20°C. Avoid repeated freeze-thaw cycles.
Stability / Shelf Life
The product is stable for 12 months at -20°C and 1 month at 4°C.
Applications
This antibody has been validated for ELISA and Western blot analysis to ensure specificity and reactivity. However, optimal working dilutions should be determined empirically for each application. For Western blot analysis, a dilution range of 1:500 to 1:2000 is recommended, with a starting dilution of 1:2000.
Synonyms
EC 2.7.1.11, GSD7, PFK-1, PFK1, PFKA, PFKX, Phosphofructokinase-M, Phosphofructokinase 1, Phosphohexokinase, Phosphofructo-1-kinase isozyme A, MGC8699, PFKM. 
Purification Method
PFKM antibody was purified from mouse ascitic fluids by protein-G affinity chromatography.
Type
Mouse Anti Human Monoclonal.
Clone
PAT2F11A.
Immunogen
Anti-human PFKM mAb, clone PAT2F11A, is derived from hybridization of mouse F0 myeloma cells with spleen cells from BALB/c mice immunized with a recombinant human PFKM protein. 
Ig Subclass
Mouse IgG2a heavy chain and Kappa light chain.

Product Science Overview

Definition and Classification

Phosphofructokinase (PFK) exists in three isoforms in humans: muscle (PFKM), liver (PFKL), and platelet (PFKP). These isoforms function as subunits of the mammalian tetramer phosphofructokinase, with the tetramer composition varying depending on the tissue type . The muscle isoform, PFKM, is encoded by the PFKM gene and is predominantly expressed in skeletal muscle tissue .

Biological Properties

PFKM is a homotetrameric enzyme, meaning it forms a tetramer composed of four identical subunits. The enzyme is allosterically regulated, meaning its activity can be modulated by various metabolites. For instance, ATP acts as an allosteric inhibitor, while AMP and fructose-2,6-bisphosphate serve as activators .

Expression Patterns and Tissue Distribution

PFKM is primarily expressed in skeletal muscle tissue, where it plays a critical role in regulating glycolysis during muscle contraction. It is also present in other tissues, including the heart and liver, but at lower levels .

Biological Functions

The primary function of PFKM is to catalyze the conversion of fructose-6-phosphate to fructose-1,6-bisphosphate, a key step in glycolysis. This reaction is essentially irreversible and serves as a major control point in the glycolytic pathway . By regulating this step, PFKM controls the rate of glucose metabolism and energy production in muscle cells.

Modes of Action

PFKM’s activity is regulated by various allosteric effectors. High levels of ATP inhibit PFKM, reducing glycolysis when energy is abundant. Conversely, high levels of AMP and fructose-2,6-bisphosphate activate PFKM, enhancing glycolysis when energy is needed . This regulation ensures that glycolysis is tightly controlled in response to the cell’s energy status.

Regulatory Mechanisms

PFKM is subject to both allosteric regulation and covalent modification. Allosteric regulation involves the binding of metabolites like ATP, AMP, and fructose-2,6-bisphosphate to specific sites on the enzyme, altering its activity . Covalent modification, such as phosphorylation, can also modulate PFKM activity, although this is less common compared to allosteric regulation.

Mouse Anti-Human PFKM Antibody

The Mouse Anti-Human PFKM Antibody is a monoclonal antibody that specifically detects human PFKM in various assays, including Western blot and immunohistochemistry . This antibody is valuable for research into PFKM’s role in metabolism and its regulation in different tissues.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.